Morgan Stanley raised the firm’s price target on Phibro Animal Health (PAHC) to $45 from $34 and keeps an Equal Weight rating on the shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PAHC:
- Phibro Animal Health price target raised to $50 from $45 at JPMorgan
- Phibro Animal Health Reports Strong Q1 Growth
- Phibro Animal Health Corp’s Earnings Call Highlights Robust Growth
- Phibro Animal Health reports Q1 EPS 73c, consensus 60c
- Phibro Animal Health sees FY26 EPS $2.64-$2.81, consensus $2.63